← FDA DRUG APPROVALS

FDA ANDA · ANDA078968

NICOTINE POLACRILEX

Sponsor: PERRIGO R AND D

APPLICATION
ANDA078968
TYPE
ANDA
ORIGINAL APPROVAL
2008-04-23
LATEST ACTION
2024-03-15
ROUTE
BUCCAL
DOSAGE FORM
GUM, CHEWING
MARKETING STATUS
Discontinued

Products

NICOTINE POLACRILEXDiscontinued
NICOTINE POLACRILEX EQ 4MG BASE · GUM, CHEWING · BUCCAL

Approval history

2024-03-15Labeling · Supplement 10 · standardAP
2024-03-15Labeling · Supplement 13 · standardAP
2012-11-29Labeling · Supplement 8 · standardAP
2010-06-17Labeling · Supplement 4AP
2008-04-23OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →